§¥§à§Þ

§° Goldsite

§±§â§à§Õ§å§Ü§ä§í

§¬§Ý§Ú§ß§Ú§é§Ö§ã§Ü§Ú§Û §Ú§ß§ã§ä§â§å§Þ§Ö§ß§ä

§²§Ö§Ñ§Ô§Ö§ß§ä§í

§²§Ñ§ã§ç§à§Õ§ß§í§Û §Þ§Ñ§ä§Ö§â§Ú§Ñ§Ý

§£§Ö§ä§Ö§â§Ú§ß§Ñ§â§Ú§ñ

§¢§Ú§à§ä§Ö§ç§ß§à§Ý§à§Ô§Ú§é§Ö§ã§Ü§Ñ§ñ §Ñ§Ó§ä§à§Þ§Ñ§ä§Ú§Ù§Ñ§è§Ú§ñ

§²§Ö§ê§Ö§ß§Ú§ñ

§¯§à§Ó§à§ã§ä§Ú

§±§à§Õ§Õ§Ö§â§Ø§Ú§Ó§Ñ§ä§î

§³§Ü§Ñ§é§Ñ§ä§î

§³§Ó§ñ§Ù§Ñ§ä§î§ã§ñ §ã §ß§Ñ§Þ§Ú

P§å§ã§ã§Ü§Ú§Û
Français
Deutsch
???????
Português
Español
English
¼òÌåÖÐÎÄ

§¯§à§Ó§à§ã§ä§Ú
§¥§à§Þ / §¯§à§Ó§à§ã§ä§Ú
  • 12 §Þ§Ñ§â§ä§Ñ §ê§ï§ß§î§é§Ø§ï§ß§î§ã§Ü§Ú§Û §ß§Ñ§Ò§à§â Goldsite SARS-CoV-2 IgM/IgG (§ã §Ú§ã§á§à§Ý§î§Ù§à§Ó§Ñ§ß§Ú§Ö§Þ §æ§Ý§å§à§â§Ö§ã§è§Ö§ß§ä§ß§à§Ô§à §Ú§Þ§Þ§å§ß§à§Ñ§ß§Ñ§Ý§Ú§Ù§Ñ §ã §Ó§â§Ö§Þ§Ö§ß§ß§í§Þ §â§Ñ§Ù§â§Ö§ê§Ö§ß§Ú§Ö§Þ) §Ò§í§Ý §à§Õ§à§Ò§â§Ö§ß §¦§³ §ã §Þ§Ñ§â§Ü§Ú§â§à§Ó§Ü§à§Û CE. CE §à§Ù§ß§Ñ§é§Ñ§Ö§ä CONFORMITE EUROPEENNE.§©§ß§Ñ§Ü CE §å§Ü§Ñ§Ù§í§Ó§Ñ§Ö§ä §ß§Ñ §ä§à, §é§ä§à §á§â§à§Õ§å§Ü§ä §ã§à§à§ä§Ó§Ö§ä§ã§ä§Ó§å§Ö§ä §Ó§ã§Ö§Þ §ã§à§à§ä§Ó§Ö§ä§ã§ä§Ó§å§ð§ë§Ú§Þ §Õ§Ú§â§Ö§Ü§ä§Ú§Ó§Ñ§Þ §¦§Ó§â§à§á§Ö§Û§ã§Ü§à§Û §¬§à§Þ§Ú§ã§ã§Ú§Ú, §Ú §ã§Ú§Þ§Ó§à§Ý§Ú§Ù§Ú§â§å§Ö§ä c.
  • Goldsite §Ú§Þ§Ö§Ö§ä 21-§Ý§Ö§ä§ß§Ú§Û §à§á§í§ä §â§Ñ§Ò§à§ä§í §Ó §à§Ò§Ý§Ñ§ã§ä§Ú §á§â§à§Ú§Ù§Ó§à§Õ§ã§ä§Ó§Ñ §Ú §â§Ñ§Ù§â§Ñ§Ò§à§ä§Ü§Ú §â§Ö§Ñ§Ô§Ö§ß§ä§à§Ó §Ú §Ú§ß§ã§ä§â§å§Þ§Ö§ß§ä§à§Ó §Õ§Ý§ñ IVD.§®§í §Ù§Ñ§Ò§à§ä§Ú§Þ§ã§ñ §à §Õ§à§Þ§Ñ§ê§ß§Ú§ç §Ø§Ú§Ó§à§ä§ß§í§ç.§¯§Ñ§ê§Ñ §Ü§à§Þ§Ñ§ß§Õ§Ñ §â§Ñ§Ò§à§ä§Ñ§Ö§ä §Ü§Ñ§Ø§Õ§í§Û §Õ§Ö§ß§î, §é§ä§à§Ò§í §Ý§å§é§ê§Ö §á§à§ß§ñ§ä§î §Ú §â§Ö§ê§Ú§ä§î §â§Ö§Ñ§Ý§î§ß§í§Ö §á§â§à§Ò§Ý§Ö§Þ§í, §ã §Ü§à§ä§à§â§í§Þ§Ú §ã§ä§Ñ§Ý§Ü§Ú§Ó§Ñ§ð§ä§ã§ñ §ß§Ñ§ê§Ú §Ü§Ý§Ú§Ö§ß§ä§í, §Ü§à§ä§à§â§í§Ö §Ó§í§â§Ñ§ë§Ú§Ó§Ñ§ð§ä §Õ§à§Þ§Ñ§ê§ß§Ú§ç §Ø§Ú§Ó§à§ä§ß§í§ç §Ú §å§ç§Ñ§Ø§Ú§Ó§Ñ§ð§ä §Ù§Ñ §ß§Ú§Þ§Ú.§±§à§Þ§à§é§î §Õ§à§Þ§Ñ§ê§ß§Ú§Þ §Ø§Ú§Ó§à§ä§ß§í§Þ §Ø§Ú§ä§î §Õ§à§Ý§î§ê§Ö §Ú §Ù§Õ§à§â§à§Ó§Ö§Ö
  • GPP-100, §á§â§Ú§Ó§Ý§Ö§Ü§Ñ§ä§Ö§Ý§î§ß§í§Û §Ú§ß§ß§à§Ó§Ñ§è§Ú§à§ß§ß§í§Û §Ò§Ö§Ý§Ü§à§Ó§í§Û §á§â§à§Õ§å§Ü§ä §Ü§à§Þ§á§Ñ§ß§Ú§Ú Goldsite, §ß§Ñ§é§Ú§ß§Ñ§Ö§ä §ã§Ó§à§Ö §á§å§ä§Ö§ê§Ö§ã§ä§Ó§Ú§Ö §Ó §º§Ó§Ö§è§Ú§ð §Ó §Õ§Ö§Ü§Ñ§Ò§â§Ö 2019 §Ô§à§Õ§Ñ. §³ §Þ§à§Þ§Ö§ß§ä§Ñ §ã§Ó§à§Ö§Ô§à §Ù§Ñ§á§å§ã§Ü§Ñ §Ó 2018 §Ô§à§Õ§å GPP-100 §Ò§í§Ý §å§ã§ä§Ñ§ß§à§Ó§Ý§Ö§ß §Ó§à §Þ§ß§à§Ô§Ú§ç §ã§ä§â§Ñ§ß§Ñ§ç, §Ó§Ü§Ý§ð§é§Ñ§ñ §ª§ß§Õ§Ú§ð, §¶§Ú§Ý§Ú§á§á§Ú§ß§í, §¬§Ñ§ä§Ñ§â. , SA, §²§å§Þ§í§ß§Ú§ñ §Ú §ä. §Õ. §¦§Ô§à §à§ä§Ý§Ú§é§ß§Ñ§ñ §Ú §ã§ä§Ñ§Ò§Ú§Ý§î§ß§Ñ§ñ §â§Ñ§Ò§à§ä§Ñ §á§â§à§Ú§Ù§Ó§Ö§Ý§Ñ §Ó§á§Ö§é§Ñ§ä§Ý§Ö§ß§Ú§Ö §ß§Ñ §Ü§Ý§Ú§Ö§ß§ä§à§Ó.
  • §¦§Ø§Ö§Ô§à§Õ§ß§Ñ§ñ §Þ§Ö§Ø§Õ§å§ß§Ñ§â§à§Õ§ß§Ñ§ñ §Þ§Ö§Õ§Ú§è§Ú§ß§ã§Ü§Ñ§ñ §Ó§í§ã§ä§Ñ§Ó§Ü§Ñ MEDICA, §à§ä§Ü§â§í§Ó§ê§Ñ§ñ§ã§ñ 18 §ß§à§ñ§Ò§â§ñ 2019 §Ô§à§Õ§Ñ §Ó §¥§ð§ã§ã§Ö§Ý§î§Õ§à§â§æ§Ö, §¤§Ö§â§Þ§Ñ§ß§Ú§ñ, §ã§à§Ò§â§Ñ§Ý§Ñ §ï§Ü§ã§á§à§ß§Ö§ß§ä§à§Ó §Ú §á§à§ã§Ö§ä§Ú§ä§Ö§Ý§Ö§Û §Ú§Ù §Ò§à§Ý§Ö§Ö §é§Ö§Þ 100 §ã§ä§â§Ñ§ß §Ú §â§Ö§Ô§Ú§à§ß§à§Ó §Þ§Ú§â§Ñ.§¢§å§Õ§å§é§Ú §ã§Ñ§Þ§à§Û §Ú§Ù§Ó§Ö§ã§ä§ß§à§Û §Ü§à§Þ§á§Ý§Ö§Ü§ã§ß§à§Û §Þ§Ö§Õ§Ú§è§Ú§ß§ã§Ü§à§Û §Ó§í§ã§ä§Ñ§Ó§Ü§à§Û §Ó ??§Þ§Ú§â§Ö, §ï§ä§Ñ §Ó§í§ã§ä§Ñ§Ó§Ü§Ñ h
Goldsite Diagnostics Inc., §à§ã§ß§à§Ó§Ñ§ß§ß§Ñ§ñ §Ó 1999 §Ô§à§Õ§å, §ñ§Ó§Ý§ñ§Ö§ä§ã§ñ §Ó§Ö§Õ§å§ë§Ú§Þ §Ü§Ú§ä§Ñ§Û§ã§Ü§Ú§Þ §á§â§à§Ú§Ù§Ó§à§Õ§Ú§ä§Ö§Ý§Ö§Þ §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§é§Ö§ã§Ü§Ú§ç §ã§â§Ö§Õ§ã§ä§Ó, §ã§á§Ö§è§Ú§Ñ§Ý§Ú§Ù§Ú§â§å§ð§ë§Ú§Þ§ã§ñ §ß§Ñ §å§ã§ä§â§à§Û§ã§ä§Ó§Ñ§ç §Ú §â§Ö§Ñ§Ô§Ö§ß§ä§Ñ§ç §Õ§Ý§ñ §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ú in vitro.

§³§Ó§ñ§Ù§Ñ§ä§î§ã§ñ

? (+86)-755-26890807

    (+86)-755-26897973
? export@

 

Copyright © 1999¨C2023 Goldsite Diagnostics Inc., §£§ã§Ö §á§â§Ñ§Ó§Ñ §Ù§Ñ§ë§Ú§ë§Ö§ß§í. Sitemap